Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr370.10 DKK
Change Today +13.00 / 3.64%
Volume 3.5M
NOVOB On Other Exchanges
New York
As of 11:07 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henrik Sandvad Rasmussen M.D., Ph.D.

Vice President of Clinical Medical and Regulatory Affairs,Novo Nordisk A/S
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 7 different industries.



Dr. Henrik Sandvad Rasmussen, M.D., Ph.D. has been the Chief Medical Officer of ZS Pharma, Inc. since October 2012. Dr. Rasmussen serves as General Counsel, Corporate Affairs of VKR Holding A/S. He served as Chief Scientific Officer of ZS Pharma, Inc. since October 2012. Dr. Rasmussen served as CMO Consultant at Vaxin, Inc. Dr. Rasmussen served as the Vice President of Clinical Medical and Regulatory Affairs for Novo Nordisk A/S since February 16, 2007. Dr. Rasmussen ...

Read Full Background

Corporate Headquarters*

Novo Allé
Bagsvaerd, Capital Region of Denmark 2880


Phone: 45 44 44 88 88
Fax: 45 44 49 05 55

Board Members Memberships*

There is no Board Members Memberships data available.


PhD 1992
Københavns Universitet
Københavns Universitet
Bachelor's Degree
Open University Business School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NOVOB:DC kr370.10 DKK +13.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at